Wellington Management Group
LENZ

Wellington Management Group’s LENZ Therapeutics LENZ Stock Holding History

Wellington Management Group’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-54,402
Closed -$870K – 2028
2025
Q4 		$870K Sell
54,402
-6,919
-11% -$202K ﹤0.01% 1735
2025
Q3 		$2.86M Buy
61,321
+26,494
+76% +$974K ﹤0.01% 1562
2025
Q2 		$1.02M Buy
34,827
+4,339
+14% +$118K ﹤0.01% 1717
2025
Q1 		$784K Buy
30,488
+2,272
+8% +$56K ﹤0.01% 1758
2024
Q4 		$815K Buy
28,216
+3,595
+15% +$110K ﹤0.01% 1754
2024
Q3 		$585K Buy
+24,621
New +$546K ﹤0.01% 1798

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Wellington Management Group's LENZ Position: Q1 2026 in Review

Wellington Management Group sold out of LENZ Therapeutics (LENZ) in Q1 2026, closing a stake of 54,402 shares — an estimated $870K sold.

Wellington Management Group first reported a position in LENZ in Q3 2024 and held it in 6 quarters. The position peaked at $2.86M in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Wellington Management Group reported no remaining LENZ Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Wellington Management Group sold 54,402 LENZ Therapeutics shares in Q1 2026, an estimated $870K.
  • Wellington Management Group first reported a position in LENZ Therapeutics in Q3 2024 and held it in 6 quarters.
  • Wellington Management Group's LENZ Therapeutics position peaked at $2.86M in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.